BRCA Genetic Testing and Receipt of Preventive Interventions Among Women Aged 18–64 Years with Employer-Sponsored Health Insurance in Nonmetropolitan and Metropolitan Areas — United States, 2009–2014

PROBLEM/CONDITION: Genetic testing for breast cancer 1 (BRCA1) and breast cancer 2 (BRCA2) gene mutations can identify women at increased risk for breast and ovarian cancer. These testing results can be used to select preventive interventions and guide treatment. Differences between nonmetropolitan...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolor, Katherine, Chen, Zhuo, Grosse, Scott D., Rodriguez, Juan L., Green, Ridgely Fisk, Dotson, W. David, Bowen, M. Scott, Lynch, Julie A., Khoury, Muin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2017
Materias:
Surveillance Summaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879728/
https://www.ncbi.nlm.nih.gov/pubmed/28880857
http://dx.doi.org/10.15585/mmwr.ss6615a1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879728/
https://www.ncbi.nlm.nih.gov/pubmed/28880857
http://dx.doi.org/10.15585/mmwr.ss6615a1

Ejemplares similares